Fund HoldingsMerck & Co., Inc.

Total Portfolio Value
$526.41M
Total Bought
$25.61M
Total Sold
$33.30M
Net Transaction
-$7.69M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
PERSONALIS INC(PSNL)14,044,94314,044,943089,466188,20235.75%+98,736
MODERNA INC(MRNA)2,308,1902,308,1900117,256161,64330.71%+44,386
KYMERA THERAPEUTICS INC(KYMR)772,165772,165064,31488,54416.82%+24,231
AKTIS ONCOLOGY INC(AKTS)952,844952,844017,04630,7105.83%+13,664
ENTRADA THERAPEUTICS INC(TRDA)01,739,768+1,739,768012,8052.43%+12,805
SUTRO BIOPHARMA INC(STRO)0272,351+272,35109,0421.72%+9,042
EIKON THERAPEUTICS INC(EIKN)1,666,6661,666,666017,63321,7504.13%+4,117
EVAXION BIOTECH A/S(EVAX)01,214,126+1,214,12603,7640.71%+3,764
XILIO THERAPEUTICS INC(XLO)105,982105,98208911,0150.19%+124
TUHURA BIOSCIENCES INC(HURA)19,44519,445035460.01%+11
NEUPHORIA THERAPEUTICS INC10,02710,027041440.01%+3
CARISMA THERAPEUTICS INC1,473,2400-1,473,240480-48
VIRIDIAN THERAPEUTICS INC(VRDN)93,41493,41401,8271,7160.33%-111
ALECTOR INC3,545,7193,545,71907,6237,1271.35%-496
EVAXION BIOTECH A/S1,214,1260-1,214,1264,5170-4,517
SUTRO BIOPHARMA INC(STRO)272,3510-272,3516,7840-6,784
ENTRADA THERAPEUTICS INC(TRDA)1,739,7680-1,739,76821,9560-21,956
Page 1 of 1
Merck & Co., Inc. — 13F Holdings — Q2 2026 | TickerTrail